Price target
Based on analysts projections #SRPT is expected to experience a positive growth trajectory over the next year.
The current average SRPT price target, as estimated by these analysts, is $148.67.
The predictions for the future SRPT stock price range from a low of $94.00 to a high of $187.00, highlighting the variability of market expectations for SRPT.
It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.
SRPT stock forecasts by analyst
| Analyst / firm | Date | Rating | Price target | Price when posted |
|---|---|---|---|---|
|
Matthew Harrison Morgan Stanley |
March 1, 2023 | Buy | 187.00 | 145.01 |
| Credit Suisse | January 10, 2023 | Buy | 114.00 | 117.53 |
| Needham | January 10, 2023 | Buy | 160.00 | 117.53 |
| BTIG | December 22, 2022 | Buy | 160.00 | 132.13 |
| UBS | December 16, 2022 | Buy | 158.00 | 123.56 |
|
Gil Blum Needham |
November 3, 2022 | Buy | 158.00 | 105.01 |
| Morgan Stanley | September 8, 2022 | Buy | 135.00 | 116.57 |
|
Hartaj Singh Oppenheimer |
August 15, 2022 | Buy | 150.00 | 109.00 |
| Morgan Stanley | August 3, 2022 | Buy | 100.00 | 95.20 |
| Needham | July 29, 2022 | Buy | 162.00 | 93.96 |
| Morgan Stanley | July 15, 2022 | Sell | 80.00 | 84.04 |
| Goldman Sachs | May 24, 2022 | Buy | 155.00 | 68.84 |
|
Zhiqiang Shu Berenberg Bank |
March 2, 2022 | Buy | 94.00 | 79.56 |
|
Gil Blum Needham |
March 2, 2022 | Buy | 150.00 | 79.56 |
|
Uy Ear Mizuho Securities |
January 10, 2022 | Buy | 160.00 | 76.15 |
|
Yun Zhong BTIG |
January 5, 2022 | Buy | 125.00 | 84.09 |
|
Hartaj Singh Oppenheimer |
January 4, 2022 | Buy | 125.00 | 89.16 |
|
Judah Frommer Credit Suisse |
October 15, 2021 | Buy | 95.00 | 84.19 |
Sarepta Therapeutics (SRPT) Fundamentals Checker
Financial metrics are used to evaluate financial stability which helps analysts determine if Sarepta Therapeutics is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.
Buy
Financial Scores
Updated on: 29/11/2023
Altman Z-Score: 0.7
Piotroski Score: 5.0
ESG Score
Updated on: 29/11/2023
Environmental: 58.9
Social: 64.8
Governance: 65.7
Financial Health
Updated on: 29/11/2023
DCF: Strong Buy
ROE: Sell
ROA: Neutral
Debt to equity ratio: Strong Buy
Price to earnings ratio: Strong Sell
Price to book ratio: Strong Buy
SRPT Discounted Cash Flow
Updated on: 29/11/2023
$110.232
Discounted Cash Flow Value
$83.090
Current Price
SRPT Revenues by Segment
Updated on: 29/11/2023
No available data
Revenue from Contract with Customer, Excluding Assessed Tax
SRPT Revenues by Region
Updated on: 29/11/2023
SRPT Notes Due
Updated on: 29/11/2023
| CIK | Exchange | Title |
|---|
There are no data to display
Sarepta Therapeutics (SRPT) Social Sentiments
Monitoring bullish and bearish sentiments towards Sarepta Therapeutics on Twitter and Stocktwits could help to forecast an upward or downward trend in Sarepta Therapeutics stock price.